Santa Monica, CA, United States of America

Daniel L Kaufman

This inventor holds 28 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in GABA Agonists Research. Top assignees: University of California, Other. Active years: 1995-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel L Kaufman. Retrieved from https://idiyas.com/inventor/daniel-l-kaufman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 5)

% Patents Active = 89.3

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 382(Granted Patents)

Location History:

Petach-Tikva, IL (2010)
Pasadena, CA (US) (2011)
Santa Monica, CA (US) (1995 - 2015)
New York, NY (US) (2016)
Los Angeles, CA (US) (2009 - 2024)

Company Filing History:

24 out of 16,025

University of California

patents

4 out of 834,513

Other

patents

Years Active: 1995-2024

Loading Chart...

Areas of Expertise:

GABA Agonists

Metabolic Syndrome

Opioid Receptors

Neuronal Outgrowth

Cloned Glutamic Acid Decarboxylase

Autoimmune Diseases

Peptides

Monoclonal Antibodies

Insulin-Dependent Diabetes

T Cell Responses

Nucleic Acids

Diagnostic Methods

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11992495 - Enhancing GABA's ability to modulate immune responses (2024-05-28),

2. 11872200 - GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes (2024-01-16),

3. 10952980 - GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes (2021-03-23),

4. 10434078 - GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes (2019-10-08),

5. 9820955 - GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes (2017-11-21),

6. 9335895 - Systems and methods for interactively displaying user images (2016-05-10),

7. 9089531 - GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes (2015-07-28),

8. 8926966 - Cloned glutamic acid decarboxylase (2015-01-06),

9. 8061672 - Clamping device for securing metal struts to I-beams for interior wall construction (2011-11-22),

10. 7784467 - Skin lesion protector (2010-08-31),

11. 7723071 - DNA molecules encoding opioid receptors and methods of use thereof (2010-05-25),

12. 7553484 - Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule (2009-06-30),

13. 7329511 - Nucleic acid encoding GAD65 (2008-02-12),

14. 7282563 - Opioid receptors and methods of use (2007-10-16),

15. 6682906 - Cloned glutamic acid decarboxylase (2004-01-27),

Title: The Innovative Journey of Daniel L Kaufman

Introduction: Daniel L Kaufman, a talented inventor based in Santa Monica, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Daniel L Kaufman holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, Daniel L Kaufman has worked with leading tech companies, bringing his unique vision and expertise to the development of cutting-edge products and technologies.

Collaborations: Throughout his career, Daniel L Kaufman has collaborated with top researchers, engineers, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Daniel L Kaufman's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.